ICICI Prudential Asset Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,684
Closed -$861K 156
2025
Q4
$861K Buy
4,684
+173
+4% +$30.3K 0.1% 128
2025
Q3
$692K Buy
4,511
+776
+21% +$117K 0.07% 138
2025
Q2
$522K Buy
3,735
+1
+0% +$140 0.07% 134
2025
Q1
$549K Sell
3,734
-58
-2% -$8.39K 0.07% 129
2024
Q4
$497K Sell
3,792
-9
-0.2% -$1.26K 0.05% 142
2024
Q3
$592K Buy
3,801
+603
+19% +$97.3K 0.06% 127
2024
Q2
$499K Buy
3,198
+299
+10% +$45K 0.06% 125
2024
Q1
$393K Buy
2,899
+73
+3% +$9.67K 0.04% 140
2023
Q4
$381K Buy
2,826
+234
+9% +$30.4K 0.04% 128
2023
Q3
$351K Buy
2,592
+580
+29% +$79.2K 0.05% 125
2023
Q2
$288K Buy
2,012
+82
+4% +$12.1K 0.04% 124
2023
Q1
$268K Buy
1,930
+396
+26% +$53.3K 0.04% 115
2022
Q4
$208K Buy
1,534
+447
+41% +$56.1K 0.03% 111
2022
Q3
$119K Buy
1,087
+225
+26% +$28.5K 0.02% 120
2022
Q2
$115K Buy
862
+42
+5% +$5.51K 0.02% 115
2022
Q1
$110K Buy
+820
New +$98.3K 0.01% 124

Other funds holding AZN

ICICI Prudential Asset Management's AZN Position: Q1 2026 in Review

ICICI Prudential Asset Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 4,684 shares — an estimated $861K sold.

ICICI Prudential Asset Management first reported a position in AZN in Q1 2022 and held it in 16 quarters. The position peaked at $861K in Q4 2025. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • ICICI Prudential Asset Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • ICICI Prudential Asset Management sold 4,684 AstraZeneca shares in Q1 2026, an estimated $861K.
  • ICICI Prudential Asset Management first reported a position in AstraZeneca in Q1 2022 and held it in 16 quarters.
  • ICICI Prudential Asset Management's AstraZeneca position peaked at $861K in Q4 2025.
  • 1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on ICICI Prudential Asset Management's 13F filing for Q1 2026, filed 11 May 2026.